ResearcherCentre Hospitalier Universitaire de ReimsActive in the last 2 years
Florian Slimano
Matched on ORCID iD 0000-0001-5139-7034; OpenAlex author ID A5023996609. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 2 papers · 2024: none · 2025: 1 paper
Papers 3
- Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiother… Co-author DOI 10.1038/s41430-025-01566-5↗
- Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pancreatic adenocarcinoma: A retrospective … Co-author DOI 10.1016/j.pan.2023.03.005↗
- Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC). Last author DOI 10.3389/fphar.2023.1137791↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mathias Brügel · 3 shared papers, 2023–2025 · strength 0.59
- Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
- Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791↗
- Marine Perrier · 3 shared papers, 2023–2025 · strength 0.59
- Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
- Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791↗
- Olivier Bouché · 3 shared papers, 2023–2025 · strength 0.59
- Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
- Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791↗
- Éric François · 1 shared paper, 2025 · strength 0.22
- Antoine Le Bozec · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.